New technology replaces permanent tattoo markings in cancer patients

Cancer patients at Hull's Castle Hill Hospital will soon benefit from a groundbreaking advancement in radiotherapy, eliminating the need for permanent tattoo markings that have traditionally guided their treatment. The introduction of Surface Guided Radiotherapy (SGRT) at the Queen’s Centre, backed by a £1.4 million investment, marks a significant leap forward in patient care. The NHS Humber Health Partnership has emphasized that this innovative technology will enhance the efficiency of radiographers in delivering treatment. Unlike before, where patients received tattoos during CT planning scans to pinpoint radiation delivery, most individuals will now be spared from this permanent reminder of their cancer journey. Nikki Mullins, a specialist in radiotherapy physics, shared her enthusiasm for the new system: “This cutting-edge technology employs high-tech infra-red cameras to continuously monitor patients throughout their treatment, ensuring remarkable accuracy within sub-millimetre precision. This advancement not only streamlines the treatment process but also alleviates the need for tattoos, providing a more compassionate approach to cancer care.” Radiotherapy involves administering high doses of radiation with pinpoint accuracy to the affected areas, safeguarding surrounding tissues and organs. With SGRT, patients can look forward to a more comfortable experience while receiving the precise treatment they need.

Viewed By: